Topic: Excessive pricing

Disney illegally requires streaming rivals to offer ESPN, subscribers allege

The Walt Disney Company has used its control of Hulu and ESPN to inflate online television streaming prices, a proposed class action lawsuit has alleged.

22 November 2022

Behavioural economist to give novel evidence in UK class action

The UK’s Competition Appeal Tribunal has allowed a behavioural economist to provide an expert witness statement for the first time in a collective action, as a class of claimants seeks to clarify the losses allegedly caused by telecommunications company BT.

21 November 2022

UK wastewater companies face calls for excessive pricing probe

An economic consultancy has urged the UK’s Competition and Markets Authority to launch an abuse of dominance investigation into several English wastewater companies that it claims exploited their market power to overcharge households by over £163 million.

16 November 2022

Spain fines drugmaker over €10 million for excessive pricing

Spain’s competition authority has become the latest enforcer to fine Leadiant Biosciences for abusing its dominance by overcharging its national health system for an orphan drug used to treat a rare metabolic disease.

15 November 2022

Separate trials not possible in Apple class action, CAT rules

The UK’s Competition Appeal Tribunal has rejected Apple’s request to hold a separate trial on market definition and dominance in a £1.5 billion class action claim against the technology company, finding it is impossible to establish a “clean split” between those issues and the alleged abuse.

21 October 2022

Excessive Pricing

Featured in The Guide to Life Sciences - First Edition

The pharmaceutical sector has seen mounting regulatory interest in alleged excessive pricing practices in recent years, leading to increased antitrust scrutiny of pharmaceutical pricing, pricing negotiations with health authorities and supply practices.

21 October 2022

An Economist’s Perspective

Featured in The Guide to Life Sciences - First Edition

Economically, competition issues like the exploitative abuse of dominance through excessive pricing and the exclusion of actual or potential/nascent competitors via rebates and discounts or killer acquisitions profoundly affect the pharmaceutical industry.

21 October 2022

Korea raids Apple over excessive pricing allegations

Korea’s antitrust watchdog has reportedly searched Apple's local headquarters in response to a mobile gaming association’s complaint that the technology giant unlawfully charged game developers excessive in-app purchase fees.

28 September 2022

Pennsylvania court: “Overall anticompetitive scheme” alleged in Suboxone litigation

A swathe of claims from direct purchasers, end consumers and state attorneys general accusing Indivior of monopolising the market for opioid addiction treatment Suboxone have survived the pharmaceutical company’s motion for summary judgment.

24 August 2022

South Africa opens excessive pricing probe into Sasol Gas price hike

South Africa’s antitrust watchdog has launched a probe into the country’s largest natural gas supplier, investigating whether its decision to increase gas prices by 96% constitutes excessive pricing.

17 August 2022

Unlock unlimited access to all Global Competition Review content